Illumina, Inc. (ILMN) News

Illumina, Inc. (ILMN)

Today's Latest Price: $340.82 USD

6.48 (1.94%)

Updated Dec 2 4:00pm

Add ILMN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Filter ILMN News Items

ILMN News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest ILMN News From Around the Web

Below are the latest news stories about Illumina Inc that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

Top Analyst Upgrades and Downgrades: Delta, Hasbro, Illumina, Lululemon, Micron, Nike, Penn National, Shopify, Southwest, Starbucks, Zynga and More

No summary available.

24/7 Wall street | September 30, 2020

Gene Expression Market Reflect a Holistic Expansion With Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Bio-Rad Laboratories, OriGene Technologies, Illumina, Inc., QIAGEN

A report by The Insight Partner's on the Gene Expression Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the

OpenPR | September 29, 2020

Global Function Driven Metagenomics Market Projected To Show Strong Growth By 2026 | |Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation

The numerous recent developments, products launches, research, joint ventures, mergers and acquisitions in the Function Driven Metagenomics market which is changing the face healthcare industry.We at Data Bridge Market Research understand what is important in the Function Driven

OpenPR | September 29, 2020

Week In Review: Illumina Pays $8 Billion To Acquire GRAIL, An Early-Stage Cancer Testing Company

Deals and Financings Illumina (ILMN) will acquire GRAIL (GRAL), an Illumina spin-out that is developing an early screening test for multiple forms of cancer, for $8 billion in cash and stock (see story). In 2017, GRAIL bought Cirina, a Hong Kong-San Francisco liquid biopsy company cofounded by Dr. Dennis Lo,...

ChinaBio Today on Seeking Alpha | September 28, 2020

Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020

SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details

Business Wire | September 28, 2020

Has the era of liquid biopsies finally arrived? Illumina thinks so

Illumina's (ILMN) $8B takeout of liquid biopsy developer GRAIL, which it formed in 2016 with funding assistance from the likes of Bill Gates and Jeff Bezos, may be a watershed event for its use in cancer detection and management.It is developing a multi-cancer early detection test called Galleri that detects...

Seeking Alpha | September 26, 2020

Illumina and Grail CEOs defend their deal to investors

The CEOs of the two companies told STAT it would take time for investors to understand the advantages of combining the two firms.

STAT News | September 25, 2020

New Leadership Driving New Interest In Pacific Biosciences

It's been a little wild lately for Pacific Biosciences (PACB) ("PacBio"). While there have been several strong names in life sciences over the past three months and on a year-to-date basis, including companies like 10x Genomics (TXG), Berkeley Lights (BLI), and Nanostring (NSTG), PacBio has sprinted ahead about 125% since...

Stephen Simpson, CFA on Seeking Alpha | September 23, 2020

Illumina (ILMN) CEO Francis deSouza on Illumina to Acquire GRAIL Conference Call (Transcript)

Illumina (ILMN) Illumina to Acquire GRAIL Conference Call September 21, 2020 8:00 A.M. ET Company Participants Jacquie Ross - Vice President, Investor Relations Francis deSouza - President and Chief Executive Officer Sam Samad - Chief Financial Officer Hans Bishop - Chief Executive Officer, GRAIL Conference Call Participants Doug Schenkel -...

SA Transcripts on Seeking Alpha | September 22, 2020

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More

No summary available.

24/7 Wall street | September 22, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.576 seconds.